{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-001830","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2026-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.079547+00:00","generated_at":"2026-05-15T08:19:29.601306+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"VolitionRx FY2025 revenue up 40% to $1.7M; net loss down 14%","bullets":["Full-year revenue $1.7M (+40% YoY); Q4 revenue growth 133% vs prior year.","Operating expenses down $4.8M (17%); net cash used in ops $19.7M (-24%).","Received first order for Nu.Q Cancer assays for lung cancer clinical certification.","Nu.Q NETs assay included in French government-backed sepsis study (~$7.3M).","Subsequent to year end: raised $5.4M ATM equity, $1.9M convertible note, $1.0M non-dilutive."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-001830","json":"https://secwatch.observer/filing/0001477932-26-001830.json","markdown":"https://secwatch.observer/filing/0001477932-26-001830.md","text":"https://secwatch.observer/filing/0001477932-26-001830.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001830/0001477932-26-001830-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001830/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:19:29.601306+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2f30d90accf1941ae4ead258def8fd8f8197ee3e","claim":"VOLITIONRX LTD reported full fiscal year 2025 results: revenue $1.7 million.","evidence_excerpt":"Full-year revenue for 2025 was $1.7 million, representing growth of 40% over the previous year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001830/0001477932-26-001830-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full fiscal year 2025"},{"label":"Revenue","value":"$1.7 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}